aesica queenborough limited
aesica queenborough limited Company Information
Company Number
06350087
Next Accounts
95 days late
Industry
Manufacture of basic pharmaceutical products
Shareholders
consort medical limited
Group Structure
View All
Contact
Registered Address
aesica queenborough limited, north road, queenborough, kent, ME11 5EL
Website
www.aesica-pharma.comaesica queenborough limited Estimated Valuation
Pomanda estimates the enterprise value of AESICA QUEENBOROUGH LIMITED at £60.6m based on a Turnover of £26.8m and 2.26x industry multiple (adjusted for size and gross margin).
aesica queenborough limited Estimated Valuation
Pomanda estimates the enterprise value of AESICA QUEENBOROUGH LIMITED at £0 based on an EBITDA of £-29.1m and a 9.11x industry multiple (adjusted for size and gross margin).
aesica queenborough limited Estimated Valuation
Pomanda estimates the enterprise value of AESICA QUEENBOROUGH LIMITED at £28.9m based on Net Assets of £15.3m and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Aesica Queenborough Limited Overview
Aesica Queenborough Limited is a live company located in queenborough, ME11 5EL with a Companies House number of 06350087. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in August 2007, it's largest shareholder is consort medical limited with a 100% stake. Aesica Queenborough Limited is a established, large sized company, Pomanda has estimated its turnover at £26.8m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Aesica Queenborough Limited Health Check
Pomanda's financial health check has awarded Aesica Queenborough Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
5 Weak
Size
annual sales of £26.8m, make it in line with the average company (£33m)
£26.8m - Aesica Queenborough Limited
£33m - Industry AVG
Growth
3 year (CAGR) sales growth of -19%, show it is growing at a slower rate (4.6%)
-19% - Aesica Queenborough Limited
4.6% - Industry AVG
Production
with a gross margin of 38.8%, this company has a comparable cost of product (37.5%)
38.8% - Aesica Queenborough Limited
37.5% - Industry AVG
Profitability
an operating margin of -123.1% make it less profitable than the average company (6.2%)
-123.1% - Aesica Queenborough Limited
6.2% - Industry AVG
Employees
with 277 employees, this is above the industry average (108)
277 - Aesica Queenborough Limited
108 - Industry AVG
Pay Structure
on an average salary of £39.4k, the company has a lower pay structure (£65.6k)
£39.4k - Aesica Queenborough Limited
£65.6k - Industry AVG
Efficiency
resulting in sales per employee of £96.8k, this is less efficient (£423.2k)
£96.8k - Aesica Queenborough Limited
£423.2k - Industry AVG
Debtor Days
it gets paid by customers after 62 days, this is near the average (53 days)
62 days - Aesica Queenborough Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 86 days, this is slower than average (37 days)
86 days - Aesica Queenborough Limited
37 days - Industry AVG
Stock Days
it holds stock equivalent to 64 days, this is less than average (102 days)
64 days - Aesica Queenborough Limited
102 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (11 weeks)
1 weeks - Aesica Queenborough Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 56.3%, this is a higher level of debt than the average (46.3%)
56.3% - Aesica Queenborough Limited
46.3% - Industry AVG
AESICA QUEENBOROUGH LIMITED financials
Aesica Queenborough Limited's latest turnover from December 2022 is £26.8 million and the company has net assets of £15.3 million. According to their latest financial statements, Aesica Queenborough Limited has 277 employees and maintains cash reserves of £600 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Jan 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 26,800,000 | 35,800,000 | 46,800,000 | 28,800,000 | 49,800,000 | 57,900,000 | 60,700,000 | 65,000,000 | 77,800,000 | 46,900,000 | 40,200,000 | 38,900,000 | 41,900,000 | 41,700,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | |||||||||
| Cost Of Sales | 16,400,000 | 35,500,000 | 32,800,000 | 32,900,000 | 27,900,000 | |||||||||
| Gross Profit | 10,400,000 | 4,700,000 | 6,100,000 | 9,000,000 | 13,800,000 | |||||||||
| Admin Expenses | 43,400,000 | 3,000,000 | 2,300,000 | 6,000,000 | 8,000,000 | |||||||||
| Operating Profit | -33,000,000 | -5,100,000 | -4,400,000 | -8,500,000 | -13,300,000 | 1,200,000 | 200,000 | 13,500,000 | -1,900,000 | 3,500,000 | 1,700,000 | 3,800,000 | 3,000,000 | 5,800,000 |
| Interest Payable | 400,000 | 800,000 | 900,000 | 500,000 | 600,000 | 500,000 | 500,000 | 400,000 | 500,000 | 300,000 | 300,000 | 300,000 | 100,000 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 500,000 | 0 | 0 | 0 |
| Pre-Tax Profit | -33,400,000 | -5,900,000 | -5,300,000 | -9,000,000 | -13,900,000 | 700,000 | -300,000 | 13,100,000 | 1,300,000 | 3,200,000 | 1,900,000 | 4,000,000 | 2,900,000 | 5,800,000 |
| Tax | 6,300,000 | 1,900,000 | 900,000 | 1,500,000 | 2,900,000 | 100,000 | -400,000 | -1,000,000 | -1,200,000 | 200,000 | -300,000 | -800,000 | -700,000 | -1,400,000 |
| Profit After Tax | -27,100,000 | -4,000,000 | -4,400,000 | -7,500,000 | -11,000,000 | 800,000 | -700,000 | 12,100,000 | 100,000 | 3,400,000 | 1,600,000 | 3,200,000 | 2,200,000 | 4,400,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16,500,000 | 0 | 5,000,000 | 5,000,000 | 0 | 5,000,000 |
| Retained Profit | -27,100,000 | -4,000,000 | -4,400,000 | -4,900,000 | -11,000,000 | 800,000 | -700,000 | 12,100,000 | -16,400,000 | 3,400,000 | -3,400,000 | -1,800,000 | 2,200,000 | -600,000 |
| Employee Costs | 10,900,000 | 12,500,000 | 13,800,000 | 11,500,000 | 16,100,000 | 18,600,000 | 17,200,000 | 18,200,000 | 25,500,000 | 14,300,000 | 13,700,000 | 12,100,000 | 11,500,000 | 11,300,000 |
| Number Of Employees | 277 | 287 | 369 | 388 | 418 | 457 | 468 | 443 | 429 | 367 | 355 | 356 | 327 | 339 |
| EBITDA* | -29,100,000 | -1,200,000 | -800,000 | -5,800,000 | -6,800,000 | 4,500,000 | 3,200,000 | 16,500,000 | 1,100,000 | 4,800,000 | 2,900,000 | 4,400,000 | 3,300,000 | 6,000,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Jan 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 13,400,000 | 37,900,000 | 37,200,000 | 39,200,000 | 35,700,000 | 36,700,000 | 37,800,000 | 35,600,000 | 33,500,000 | 38,200,000 | 21,400,000 | 16,600,000 | 13,300,000 | 7,000,000 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 5,800,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,200,000 | 4,200,000 | 4,200,000 | 4,200,000 | 0 |
| Debtors (Due After 1 year) | 0 | 3,900,000 | 2,400,000 | 2,200,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 19,200,000 | 34,000,000 | 34,800,000 | 37,000,000 | 35,700,000 | 36,700,000 | 37,800,000 | 35,600,000 | 33,500,000 | 38,200,000 | 21,400,000 | 16,600,000 | 13,300,000 | 7,000,000 |
| Stock & work in progress | 2,900,000 | 7,200,000 | 8,800,000 | 11,300,000 | 11,200,000 | 6,300,000 | 7,000,000 | 4,400,000 | 5,500,000 | 6,800,000 | 4,200,000 | 3,500,000 | 3,200,000 | 2,900,000 |
| Trade Debtors | 4,600,000 | 5,300,000 | 5,900,000 | 9,000,000 | 12,300,000 | 9,700,000 | 8,900,000 | 9,200,000 | 10,100,000 | 8,400,000 | 9,300,000 | 8,400,000 | 7,100,000 | 5,300,000 |
| Group Debtors | 0 | 0 | 200,000 | 100,000 | 100,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,600,000 |
| Misc Debtors | 7,700,000 | 5,300,000 | 5,100,000 | 3,600,000 | 3,200,000 | 1,600,000 | 1,500,000 | 2,300,000 | 1,100,000 | 1,500,000 | 1,200,000 | 1,000,000 | 1,200,000 | 2,000,000 |
| Cash | 600,000 | 3,200,000 | 3,800,000 | 0 | 400,000 | 2,500,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 200,000 | 0 | 0 |
| total current assets | 15,800,000 | 21,000,000 | 23,800,000 | 24,000,000 | 27,200,000 | 20,100,000 | 17,400,000 | 15,900,000 | 16,700,000 | 16,700,000 | 14,700,000 | 13,100,000 | 11,500,000 | 12,800,000 |
| total assets | 35,000,000 | 55,000,000 | 58,600,000 | 61,000,000 | 62,900,000 | 56,800,000 | 55,200,000 | 51,500,000 | 50,200,000 | 54,900,000 | 36,100,000 | 29,700,000 | 24,800,000 | 19,800,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 500,000 | 400,000 | 2,100,000 | 300,000 | 2,000,000 | 1,000,000 | 0 | 1,900,000 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 3,900,000 | 2,900,000 | 4,400,000 | 9,700,000 | 14,900,000 | 8,100,000 | 11,800,000 | 6,200,000 | 4,500,000 | 7,200,000 | 5,200,000 | 4,500,000 | 2,000,000 | 2,800,000 |
| Group/Directors Accounts | 10,600,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 1,100,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 500,000 | 700,000 | 700,000 | 800,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 2,400,000 | 6,900,000 | 67,500,000 | 57,700,000 | 12,700,000 | 6,100,000 | 8,400,000 | 14,600,000 | 10,500,000 | 8,200,000 | 8,100,000 | 4,900,000 | 7,700,000 | 5,500,000 |
| total current liabilities | 17,400,000 | 10,500,000 | 72,600,000 | 69,300,000 | 27,600,000 | 14,200,000 | 20,700,000 | 21,200,000 | 17,100,000 | 15,700,000 | 15,300,000 | 10,400,000 | 9,700,000 | 10,200,000 |
| loans | 0 | 0 | 0 | 0 | 71,800,000 | 32,000,000 | 25,400,000 | 20,400,000 | 29,400,000 | 14,400,000 | 4,200,000 | 4,200,000 | 3,200,000 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 400,000 | 5,800,000 | 10,000,000 | 5,000,000 | 0 | 0 | 0 |
| other liabilities | 400,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 1,900,000 | 4,200,000 | 5,200,000 | 7,200,000 | 2,400,000 | 2,800,000 | 1,400,000 | 800,000 | 1,800,000 | 2,800,000 | 3,200,000 | 3,400,000 | 3,400,000 | 3,200,000 |
| total long term liabilities | 2,300,000 | 2,100,000 | 2,600,000 | 3,600,000 | 37,100,000 | 33,400,000 | 26,100,000 | 21,200,000 | 36,100,000 | 25,800,000 | 10,800,000 | 5,900,000 | 4,900,000 | 1,600,000 |
| total liabilities | 19,700,000 | 12,600,000 | 75,200,000 | 72,900,000 | 64,700,000 | 47,600,000 | 46,800,000 | 42,400,000 | 53,200,000 | 41,500,000 | 26,100,000 | 16,300,000 | 14,600,000 | 11,800,000 |
| net assets | 15,300,000 | 42,400,000 | -16,600,000 | -11,900,000 | -1,800,000 | 9,200,000 | 8,400,000 | 9,100,000 | -3,000,000 | 13,400,000 | 10,000,000 | 13,400,000 | 10,200,000 | 8,000,000 |
| total shareholders funds | 15,300,000 | 42,400,000 | -16,600,000 | -11,900,000 | -1,800,000 | 9,200,000 | 8,400,000 | 9,100,000 | -3,000,000 | 13,400,000 | 10,000,000 | 13,400,000 | 10,200,000 | 8,000,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Jan 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -33,000,000 | -5,100,000 | -4,400,000 | -8,500,000 | -13,300,000 | 1,200,000 | 200,000 | 13,500,000 | -1,900,000 | 3,500,000 | 1,700,000 | 3,800,000 | 3,000,000 | 5,800,000 |
| Depreciation | 3,900,000 | 3,900,000 | 3,600,000 | 2,700,000 | 6,500,000 | 3,300,000 | 3,000,000 | 3,000,000 | 3,000,000 | 1,300,000 | 1,200,000 | 600,000 | 300,000 | 200,000 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 6,300,000 | 1,900,000 | 900,000 | 1,500,000 | 2,900,000 | 100,000 | -400,000 | -1,000,000 | -1,200,000 | 200,000 | -300,000 | -800,000 | -700,000 | -1,400,000 |
| Stock | -4,300,000 | -1,600,000 | -2,400,000 | 100,000 | 4,900,000 | -700,000 | 2,600,000 | -1,100,000 | 5,500,000 | 2,600,000 | 700,000 | 300,000 | 300,000 | 2,900,000 |
| Debtors | -2,200,000 | 900,000 | -2,000,000 | -700,000 | 4,300,000 | 900,000 | -1,100,000 | 300,000 | 11,200,000 | -600,000 | 1,100,000 | 1,100,000 | -1,600,000 | 9,900,000 |
| Creditors | 1,000,000 | -1,500,000 | -10,500,000 | -5,200,000 | 6,800,000 | -3,700,000 | 5,600,000 | 1,700,000 | 4,500,000 | 2,000,000 | 700,000 | 2,500,000 | -800,000 | 2,800,000 |
| Accruals and Deferred Income | -4,500,000 | -60,600,000 | 54,800,000 | 45,000,000 | 6,600,000 | -2,300,000 | -6,600,000 | -1,300,000 | 16,300,000 | 5,100,000 | 8,200,000 | -2,800,000 | 2,200,000 | 5,500,000 |
| Deferred Taxes & Provisions | -2,300,000 | -1,000,000 | 2,800,000 | 4,800,000 | -400,000 | 1,400,000 | 600,000 | -1,000,000 | 1,800,000 | -400,000 | -200,000 | 0 | 200,000 | 3,200,000 |
| Cash flow from operations | -22,100,000 | -61,700,000 | 51,600,000 | 40,900,000 | -100,000 | -200,000 | 900,000 | 15,700,000 | 5,800,000 | 9,700,000 | 9,500,000 | 1,900,000 | 5,500,000 | 3,300,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 5,800,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,200,000 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 10,600,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 1,100,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | -71,800,000 | -71,800,000 | 39,800,000 | 6,600,000 | 5,000,000 | -9,000,000 | 29,400,000 | 10,200,000 | 0 | 1,000,000 | 3,200,000 | 0 |
| Hire Purchase and Lease Commitments | -200,000 | 0 | 700,000 | 800,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 400,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -400,000 | -800,000 | -900,000 | -500,000 | -600,000 | -500,000 | -500,000 | -400,000 | -500,000 | -300,000 | 200,000 | -300,000 | -100,000 | 0 |
| cash flow from financing | 10,400,000 | 62,200,000 | -82,400,000 | -75,600,000 | 39,200,000 | 6,100,000 | 4,500,000 | -9,400,000 | 42,300,000 | 9,900,000 | 200,000 | 5,700,000 | 3,100,000 | 8,600,000 |
| cash and cash equivalents | ||||||||||||||
| cash | -2,600,000 | -600,000 | 3,400,000 | -400,000 | -2,100,000 | 2,500,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | -500,000 | 100,000 | -1,700,000 | 2,100,000 | -1,700,000 | 1,000,000 | 1,000,000 | -1,900,000 | 1,900,000 |
| change in cash | -2,600,000 | -600,000 | 3,400,000 | -400,000 | -2,100,000 | 3,000,000 | -100,000 | 1,700,000 | -2,100,000 | 1,700,000 | -1,000,000 | -1,000,000 | 1,900,000 | -1,900,000 |
aesica queenborough limited Credit Report and Business Information
Aesica Queenborough Limited Competitor Analysis
Perform a competitor analysis for aesica queenborough limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in ME11 area or any other competitors across 12 key performance metrics.
aesica queenborough limited Ownership
AESICA QUEENBOROUGH LIMITED group structure
Aesica Queenborough Limited has 1 subsidiary company.
Ultimate parent company
RECIPHARM AB (PUBL)
#0085293
2 parents
AESICA QUEENBOROUGH LIMITED
06350087
1 subsidiary
aesica queenborough limited directors
Aesica Queenborough Limited currently has 4 directors. The longest serving directors include Mr Thomas Eldered (Feb 2020) and Mr Gregor Kawaletz (May 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Thomas Eldered | Sweden | 64 years | Feb 2020 | - | Director |
| Mr Gregor Kawaletz | England | 57 years | May 2022 | - | Director |
| Mr Andrew Dawson | United Kingdom | 45 years | Feb 2023 | - | Director |
| Mr Emmanuel Grand | United Kingdom | 50 years | Apr 2024 | - | Director |
P&L
December 2022turnover
26.8m
-25%
operating profit
-33m
+547%
gross margin
38.9%
%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
15.3m
-0.64%
total assets
35m
-0.36%
cash
600k
-0.81%
net assets
Total assets minus all liabilities
aesica queenborough limited company details
company number
06350087
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
August 2007
age
17
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2022
previous names
N/A
accountant
-
auditor
ERNST & YOUNG LLP
address
aesica queenborough limited, north road, queenborough, kent, ME11 5EL
Bank
LLOYDS BANKING GROUP
Legal Advisor
-
aesica queenborough limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 10 charges/mortgages relating to aesica queenborough limited. Currently there are 0 open charges and 10 have been satisfied in the past.
aesica queenborough limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AESICA QUEENBOROUGH LIMITED. This can take several minutes, an email will notify you when this has completed.
aesica queenborough limited Companies House Filings - See Documents
| date | description | view/download |
|---|
